US spent near­ly $32B in pub­lic funds on mR­NA vac­cine de­vel­op­ment, study finds

The US gov­ern­ment con­tributed at least $31.9 bil­lion in pub­lic fund­ing to the de­vel­op­ment of mR­NA-based Covid-19 vac­cines, ac­cord­ing to a new BMJ study.

That in­cludes at least $337 mil­lion in the three decades pri­or to the pan­dem­ic, sev­en re­searchers from Brigham and Women’s Pro­gram On Reg­u­la­tion, Ther­a­peu­tics, And Law (POR­TAL) wrote. More than $29 bil­lion was used to pur­chase vac­cines.

For co-au­thor and pri­ma­ry care physi­cian Hus­sain Lalani, the study be­gan as a way to un­der­stand the ori­gins of mR­NA vac­cines and con­vey to pa­tients that the Covid shots were not cre­at­ed overnight.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.